Stay updated on Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial
Sign up to get notified when there's something new on the Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial page.

Latest updates to the Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded Revision: v3.5.4 and removed several topic entries (Multiple myeloma, related topics:, MedlinePlus Genetics, Revision: v3.5.3) from the topic list. This update appears to be metadata maintenance rather than changes to the study information.SummaryDifference0.1%

- Check19 days agoChange DetectedThe MAGNETISMM-5 record now lists 90 participating locations and adds MedlinePlus Genetics as a related topic, while a large number of previously listed sites—especially UK and international centers—were removed, indicating a substantial narrowing of the site network.SummaryDifference8%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page’s technical release/version label was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” without any change to the clinical trial information presented.SummaryDifference0.0%

- Check41 days agoChange DetectedAdded State of Vienna as a location and refined the Vienna address to Vienna, State of Vienna, Austria, 1160. Revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check48 days agoChange DetectedRemoved the 'Multiple myeloma' topic and the related 'MedlinePlus Genetics' topic from the page's related topics.SummaryDifference0.0%

- Check55 days agoChange DetectedAdded related topics: Multiple myeloma and MedlinePlus Genetics in the related topics section.SummaryDifference0.0%

Stay in the know with updates to Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial page.